Prot #ANG1005-CLN-03: A Phase II, Open-Label, Multi-Center Study of ANG1005 in Patients with Recurrent High-Grade Glioma

Project: Research project

Project Details

StatusFinished
Effective start/end date12/20/137/10/19

Funding

  • Integrated Therapeutic Solutions, Inc. (Prot #ANG1005-CLN-03)
  • AngioChem Inc. (Prot #ANG1005-CLN-03)